About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gabrb2tm1.1Twr
targeted mutation 1.1, Thomas W Rosahl
MGI:2177615
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gabrb2tm1.1Twr/Gabrb2tm1.1Twr involves: 129S7/SvEvBrd * C57BL/6 MGI:3713734


Genotype
MGI:3713734
hm1
Allelic
Composition
Gabrb2tm1.1Twr/Gabrb2tm1.1Twr
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gabrb2tm1.1Twr mutation (0 available); any Gabrb2 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
• at 6-10 weeks, homozygotes display minimal cochlear histopathology, with little hair cell loss outside of the extreme cochlear base
• at >24 weeks, homozygotes exhibit basal-turn histopathology
• at ~24 weeks, homozygotes display a nearly complete loss of IHCs throughout the basal 15% of the cochlear spiral, i.e., from 40 to 90 kHz according to the mouse cochlear frequency map
• at 6 weeks, OHC efferent function is significantly reduced, as assessed by measuring DPOAE suppression caused by efferent-bundle shocks; reduction is noted at test frequencies at which efferent effects are normally largest (11-32 kHz)
• by 6 weeks, immunostaining for a cholinergic marker (VAT) and a GABAergic marker (GAD) indicates loss of OHC efferent terminals in all cochlear regions, consistent with a reduction in shock-evoked efferent effects observed at this age
• however, no changes in efferent terminal development are noted up to 3 weeks of age
• importantly, no significant loss of afferent terminals is noted at 24 weeks
• at ~24 weeks, homozygotes display a nearly complete loss of OHCs throughout the basal 15% of the cochlear spiral, i.e., from 40 to 90 kHz according to the mouse cochlear frequency map
• at 6-10 weeks, homozygotes show loss of type IV fibrocytes in the spiral ligament of the basal turn
• at >24 weeks, loss of type IV fibrocytes is extended farther apically than at 6 weeks of age
• at >24 weeks, all homozygotes show limbic degeneration i.e. widespread loss of a small population of fibrocytes at a location where the spiral limbus meets the osseous spiral lamina
• however, no changes in the stria vascularis are obserevd
• at 6 weeks, amplitudes of ABR suprathreshold responses (wave 1) of homozygotes are reduced by 25-50% relative to wild-type mice, even at the highest test stimulus levels
• at 6 weeks, homozygotes display cochlear dysfunction, as shown by significant ABR threshold shifts increasing from <5 to 20-30 dB with increasing tone frequency
• at 24 weeks, cochlear dysfunction is exacerbated, as mean ABR threshold shifts are shown to peak at 45 dB for test frequencies in the middle of the cochlea (16 kHz)
• at 24 weeks, male homozygotes display significantly greater ABR threshold shifts than females; however, no sexual dimorphism is noted at 6 weeks
• at 24 weeks, ABR threshold shifts are significantly larger than the observed DPOAE shifts
• however, at 6 weeks, homozygotes show no significant differences in cochlear vulnerability to acoustic trauma (measured via ABRs and DPOAEs at 12 hrs after a 2-hr exposure to a 8-16 kHz noise band at 89 dB SPL) or in recovery from acoustic trauma at 7 days after overexposure relative to age-matched wild-type control mice
• at 6 weeks, homozygotes display increasing DPOAE threshold shifts from low to high frequencies
• at 24 weeks, ABR threshold shifts are significantly larger than the observed DPOAE shifts
• however, at 6 weeks, ABR shifts at 16 kHz (middle cochlear region) are similar in magnitude to the observed DPOAE shifts, suggesting that the ongoing degeneration is a type of neuropathy

nervous system
• at ~24 weeks, homozygotes display a nearly complete loss of IHCs throughout the basal 15% of the cochlear spiral, i.e., from 40 to 90 kHz according to the mouse cochlear frequency map
• at 6 weeks, OHC efferent function is significantly reduced, as assessed by measuring DPOAE suppression caused by efferent-bundle shocks; reduction is noted at test frequencies at which efferent effects are normally largest (11-32 kHz)
• by 6 weeks, immunostaining for a cholinergic marker (VAT) and a GABAergic marker (GAD) indicates loss of OHC efferent terminals in all cochlear regions, consistent with a reduction in shock-evoked efferent effects observed at this age
• however, no changes in efferent terminal development are noted up to 3 weeks of age
• importantly, no significant loss of afferent terminals is noted at 24 weeks
• at ~24 weeks, homozygotes display a nearly complete loss of OHCs throughout the basal 15% of the cochlear spiral, i.e., from 40 to 90 kHz according to the mouse cochlear frequency map
• at >24 weeks, homozygotes show partial loss of spiral ganglion cells but only in cochlear regions in which IHCs are degenerated

skeleton
• at 6-10 weeks, homozygotes show loss of type IV fibrocytes in the spiral ligament of the basal turn
• at >24 weeks, loss of type IV fibrocytes is extended farther apically than at 6 weeks of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory